John M. Hanson

John M. Hanson discloses dealings in Talecris Biotherapeutics Holdings Corp. to SEC (Form 4). Over a trading history stretching from 30 September 2009 to 1 June 2011, the count stands at 5 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 3 June 2011, reports a transaction in Talecris Biotherapeutics Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.